ANDA 62432, held by Mylan. Doxycycline Hyclate.
As of Nov 21, 2026, ANDA 62432 (Doxycycline Hyclate), held by Mylan, was first approved by FDA on Feb 15, 1983, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 15, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxycycline HyclateEQ 100MG BASE · tablet;oral | Doxycycline Hyclate | Discontinued |
| Jan 18, 2026 | Supplement 45Labeling · Standard review | Approved | None posted |
| Mar 31, 2025 | Supplement 44Labeling · Standard review | Approved | None posted |
| Sep 5, 2023 | Supplement 38Labeling · Standard review | Approved | None posted |
| Sep 5, 2023 | Supplement 35Labeling · Standard review | Approved | None posted |
| Sep 5, 2023 | Supplement 33Labeling · Standard review | Approved | None posted |
| Sep 5, 2023 | Supplement 31Labeling · Standard review | Approved | None posted |
| Sep 5, 2023 | Supplement 30Labeling · Standard review | Approved | None posted |
| Sep 5, 2023 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jul 28, 2017 | Supplement 32Manufacturing | Approved | None posted |
| Jun 30, 2015 | Supplement 26Labeling · Standard review | Approved | None posted |
| Sep 2, 2014 | Supplement 24Labeling · Standard review | Approved | None posted |
| Dec 23, 2002 | Supplement 23Labeling | Approved | None posted |
| Mar 14, 1996 | Supplement 20Labeling | Approved | None posted |
| Jun 1, 1993 | Supplement 15Labeling | Approved | None posted |
| Dec 16, 1992 | Supplement 14Labeling | Approved | None posted |
| Sep 24, 1991 | Supplement 13Labeling | Approved | None posted |
| Jul 16, 1991 | Supplement 12Labeling | Approved | None posted |
| Feb 15, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters